Aspen Aerogels(US:ASPN)2026-02-25 11:30Financial Performance - Total revenue for Q4 2025 was $41.3 million, a decrease of 66.5% from $123.1 million in Q4 2024[2] - Net loss for Q4 2025 was $72.9 million, compared to a net income of $11.4 million in the prior year period[3] - Full year 2025 total revenue was $271.1 million, down 40.1% from $452.7 million in 2024[5] - Full year net loss was $389.6 million, compared to a net income of $13.4 million in the prior year[6] - Adjusted EBITDA for Q4 2025 was $(18.0) million, a decline from $22.7 million in Q4 2024[4] - Gross profit for the year ended December 31, 2025, was $45,998,000, down from $182,897,000 in 2024, indicating a decrease of about 75%[29] - Adjusted EBITDA for the year ended December 31, 2025, was $2,938,000, a significant drop from $89,916,000 in 2024, representing a decline of about 97%[34] - For the twelve months ended December 31, 2025, the net loss was $389,552 thousand, translating to a loss of $4.73 per share, compared to a net income of $13,375 thousand or $0.17 per share for the same period in 2024[36] - Adjusted net income (loss) for the twelve months ended December 31, 2025, was $(40,500) thousand, or $(0.49) per share, compared to $13,375 thousand or $0.17 per share in 2024[36] Cash and Liabilities - The company ended 2025 with a cash balance of $158.6 million, up from $152.4 million at the end of Q3 2025[8] - Cash and cash equivalents at the end of the period were $158,570,000, down from $221,276,000 at the beginning of the period, indicating a decrease of approximately 28%[32] - Total liabilities as of December 31, 2025, were $171,161,000, compared to $280,439,000 in 2024, reflecting a reduction of about 39%[30] - Total stockholders' equity decreased to $235,518,000 in 2025 from $614,705,000 in 2024, a decline of approximately 62%[30] - The company reported a net cash used in financing activities of $58,129,000 for the year ended December 31, 2025, compared to a net cash provided of $122,018,000 in 2024[32] Expenses and Costs - Operating expenses for the year ended December 31, 2025, totaled $424,226,000, an increase from $128,362,000 in 2024, reflecting a rise of over 230%[30] - Research and development expenses for the year ended December 31, 2025, were $13,416,000, down from $18,050,000 in 2024, a decrease of approximately 26%[29] - The company incurred restructuring and demobilization costs of $17,510 thousand and a loss on disposal of property, plant, and equipment amounting to $18,162 thousand for the twelve months ended December 31, 2025[36] - Impairment of property, plant, and equipment was recorded at $291,164 thousand, with accelerated depreciation of $22,216 thousand for the same period[36] - Depreciation and amortization expenses are projected to be $5,000 thousand for the three months ending March 31, 2026[36] - Stock-based compensation is anticipated to be $2,500 thousand for the same period[36] - Other net expenses are also expected to be $2,500 thousand for the three months ending March 31, 2026[36] Future Projections - Q1 2026 revenue is expected to range between $35 million and $40 million, with a net loss projected between $20 million and $23 million[15] - The company expects to receive approximately $37.6 million from General Motors in Q1 2026 related to a commercial settlement[8] - For the three months ending March 31, 2026, the projected net loss is estimated to be between $(23,000) thousand and $(20,000) thousand[36] - Adjusted EBITDA for the three months ending March 31, 2026, is expected to range from $(13,000) thousand to $(10,000) thousand[36] Strategic Initiatives - Aspen initiated a strategic review to strengthen its long-term competitive positioning, engaging Piper Sandler & Co. as its financial advisor[10] - Aspen was awarded a North Sea subsea pipeline project with expected delivery in Q3 2026, expanding its market presence[14]